Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
NEW: NIH COVID-19 Treatment Guideline Update 7-8-2021
The most recent update to NIH COVID-19 Treatment Guidelines incorporates RCT data on use of antivirals, immunomodulators, and colchicine as treatment for SARS-CoV-2 infection.
The National Institutes of Health (NIH) on July 8, 2021, published a revised version of the "living" Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
Updates are made regularly based on availability for review by the COVID-19 Treatment Guidelines Panel (the Panel) of new data related to assessment and general and therapeutic management of persons at risk for or diagnosed as having infection with SARS-CoV-2.
Following are highlights of major changes made to the guidelines within the last month.
Recent Videos
Related Content
